ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

PURA Puration Inc (CE)

0.000001
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Puration Inc (CE) USOTC:PURA OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.000001 0.000001 0.000001 0.000001 100,000 01:00:00

PURA Makes Bid For Hemp4mula CBD Confections Backed By $5 Million Investment

12/02/2020 2:46pm

InvestorsHub Cannabis NewsWire


PURA Makes Bid For Hemp4mula CBD Confections Backed By $5 Million Investment

 

Dallas, TX -- February 12, 2020 -- InvestorsHub NewsWire -- Puration, Inc. (USOTC: PURA) today announced making a formal proposal to Kali-Extracts (USOTC: KALY) to acquire KALY’s Hemp4mula CBD Infused Confections operation.  On Monday, earlier this week, PURA announced closing on a $5 million investment to fund the prospective acquisition of cannabis infused beverage, edible and topical operations. The $5 million investment is structured as a debt facility whereby funds can be drawn as needed to fund acquisitions.  The drawn funds would be secured by the acquired asset and the debt can be repaid in stock at $0.10 per share.  Hemp4mula is the first target acquisition for PURA in an anticipated series of acquisitions.


Hemp4mula currently includes two products, Hemp4mula Gummies and Hemp4mula Gum each infused with 10mg of CBD extracted from hemp.

For more information on Puration, visit http://www.purationinc.com

Disclaimer/Safe Harbor: 

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. 

Contact:
Puration, Inc.
Brian Shibley,

info@aciconglomerated.com
(800) 861-1350

 

1 Year Puration (CE) Chart

1 Year Puration (CE) Chart

1 Month Puration (CE) Chart

1 Month Puration (CE) Chart

Your Recent History

Delayed Upgrade Clock